Role of cell-free network communication in alcohol-associated disorders and liver metastasis.

Alcohol-associated liver disease Colorectal cancer Exosomes Extracellular vesicles Interorgan communication Liver metastasis

Journal

World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448

Informations de publication

Date de publication:
07 Nov 2021
Historique:
received: 15 05 2021
revised: 02 07 2021
accepted: 30 09 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 15 12 2021
Statut: ppublish

Résumé

The aberrant use of alcohol is a major factor in cancer progression and metastasis. Contributing mechanisms include the systemic effects of alcohol and the exchange of bioactive molecules between cancerous and non-cancerous cells along the brain-gut-liver axis. Such interplay leads to changes in molecular, cellular, and biological functions resulting in cancer progression. Recent investigations have examined the role of extracellular vesicles (EVs) in cancer mechanisms in addition to their contribution as diagnostic biomarkers. Also, EVs are emerging as novel cell-free mediators in pathophysiological scenarios including alcohol-mediated gut microbiome dysbiosis and the release of nanosized EVs into the circulatory system. Interestingly, EVs in cancer patients are enriched with oncogenes, miRNA, lipids, and glycoproteins whose delivery into the hepatic microenvironment may be enhanced by the detrimental effects of alcohol. Proof-of-concept studies indicate that alcohol-associated liver disease is impacted by the effects of exosomes, including altered immune responses, reprogramming of stromal cells, and remodeling of the extracellular matrix. Moreover, the culmination of alcohol-related changes in the liver likely contributes to enhanced hepatic metastases and poor outcomes for cancer patients. This review summarizes the numerous aspects of exosome communications between organs with emphasis on the relationship of EVs in alcohol-associated diseases and cancer metastasis. The potential impact of EV cargo and release along a multi-organ axis is highly relevant to the promotion of tumorigenic mechanisms and metastatic disease. It is hypothesized that EVs target recipient tissues to initiate the formation of prometastatic niches and cancer progression. The study of alcohol-associated mechanisms in metastatic cancers is expected to reveal a better understanding of factors involved in the growth of secondary malignancies as well as novel approaches for therapeutic interventions.

Identifiants

pubmed: 34887629
doi: 10.3748/wjg.v27.i41.7080
pmc: PMC8613644
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

7080-7099

Subventions

Organisme : BLRD VA
ID : I01 BX004127
Pays : United States

Informations de copyright

©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: Authors declare no conflict of interests for this article.

Références

Am J Physiol Gastrointest Liver Physiol. 2012 May 1;302(9):G966-78
pubmed: 22241860
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
Clin Exp Metastasis. 2011 Dec;28(8):923-32
pubmed: 21901530
Cell Mol Life Sci. 2016 Dec;73(24):4717-4737
pubmed: 27438886
Mol Cell Proteomics. 2013 Mar;12(3):587-98
pubmed: 23230278
Gastroenterology. 2011 Nov;141(5):1572-85
pubmed: 21920463
J Gastric Cancer. 2019 Sep;19(3):301-314
pubmed: 31598373
Int J Mol Sci. 2019 Apr 19;20(8):
pubmed: 31010154
Exp Cell Res. 2020 Jun 15;391(2):111983
pubmed: 32268136
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):
pubmed: 24003212
Cancer Res. 2012 Oct 1;72(19):4920-30
pubmed: 22865453
Cancers (Basel). 2018 Jan 30;10(2):
pubmed: 29385712
JAMA Oncol. 2016 Jul 1;2(7):882-9
pubmed: 27032035
Nucleic Acids Res. 2012 Oct;40(18):9272-85
pubmed: 22821563
Methods Mol Biol. 2017;1545:189-196
pubmed: 27943215
Biosci Biotechnol Biochem. 2020 Feb;84(2):338-346
pubmed: 31631786
Proteomics. 2013 Nov;13(22):3354-64
pubmed: 24115447
Semin Liver Dis. 2016 Sep;36(4):331-339
pubmed: 27997973
Biochimie. 2014 Jan;96:67-74
pubmed: 23827857
J Cell Physiol. 2019 Nov;234(11):21380-21394
pubmed: 31102273
Front Pharmacol. 2020 Dec 21;11:603771
pubmed: 33408632
Biol Direct. 2013 Jun 07;8:12
pubmed: 23758897
Sci Rep. 2017 Jun 23;7(1):4150
pubmed: 28646161
Liver Res. 2018 Mar;2(1):30-34
pubmed: 30345152
Proteomics. 2013 May;13(10-11):1672-86
pubmed: 23585443
J Clin Lab Anal. 2019 Nov;33(9):e23004
pubmed: 31420913
J Nutr Biochem. 2003 Nov;14(11):616-25
pubmed: 14629892
Am J Physiol Cell Physiol. 2020 Jan 1;318(1):C29-C39
pubmed: 31693397
Nat Commun. 2013;4:2712
pubmed: 24231649
Clin Cancer Res. 2015 Aug 15;21(16):3578-80
pubmed: 26275951
Cell. 2015 May 7;161(4):774-89
pubmed: 25957685
J Microbiol. 2015 Dec;53(12):856-63
pubmed: 26626356
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4485-93
pubmed: 25288760
Cell Commun Signal. 2015 Feb 03;13:8
pubmed: 25644060
Nature. 2005 Jul 28;436(7050):518-24
pubmed: 16049480
Oncol Res. 2017 May 24;25(5):651-661
pubmed: 27712599
J Neuroinflammation. 2008 Mar 18;5:10
pubmed: 18348728
Clin Exp Metastasis. 1998 Nov;16(8):703-12
pubmed: 10211983
Cancer Sci. 2018 Aug;109(8):2364-2374
pubmed: 29908100
Elife. 2015 Jul 01;4:e07197
pubmed: 26132860
Gastroenterology. 2011 Oct;141(4):1323-33
pubmed: 21763238
Science. 2008 Feb 29;319(5867):1244-7
pubmed: 18309083
Cancer Biomark. 2019;24(3):299-305
pubmed: 30829615
J Neurooncol. 2018 Jan;136(1):51-62
pubmed: 29076001
Prog Lipid Res. 2017 Apr;66:30-41
pubmed: 28342835
Clin Sci (Lond). 2020 Feb 28;134(4):419-434
pubmed: 32065214
Theranostics. 2019 Mar 16;9(7):1965-1979
pubmed: 31037150
Gastroenterology. 2001 Aug;121(2):337-49
pubmed: 11487543
Front Cell Dev Biol. 2018 Feb 20;6:18
pubmed: 29515996
J Lipid Res. 2003 Apr;44(4):655-67
pubmed: 12562849
Biochim Biophys Acta. 1981 Jul 6;645(1):63-70
pubmed: 6266476
Cancer Metastasis Rev. 2013 Dec;32(3-4):643-71
pubmed: 23903773
Int J Cancer. 2012 May 1;130(9):2033-43
pubmed: 21630268
Mol Cancer. 2019 Mar 11;18(1):39
pubmed: 30857545
Int J Cancer. 2004 Feb 10;108(4):483-7
pubmed: 14696110
Cancer Biomark. 2019;25(1):11-18
pubmed: 31006664
J Biol Chem. 1987 Jul 5;262(19):9412-20
pubmed: 3597417
Eur J Cancer Prev. 2014 Nov;23(6):532-9
pubmed: 25170915
Oncotarget. 2016 Jul 12;7(28):43076-43087
pubmed: 27172798
J Histochem Cytochem. 2002 Jan;50(1):43-55
pubmed: 11748293
Sci Rep. 2016 Oct 21;6:35562
pubmed: 27765945
Addiction. 2018 Oct;113(10):1905-1926
pubmed: 29749059
Iran Biomed J. 2016 Jul 19;21(2):106-13
pubmed: 27432735
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Front Immunol. 2014 Aug 20;5:403
pubmed: 25191326
Nat Commun. 2013;4:2980
pubmed: 24356509
Curr Opin Cell Biol. 2014 Aug;29:116-25
pubmed: 24959705
Cancer Lett. 2000 Aug 31;157(1):45-50
pubmed: 10893441
Alcohol Clin Exp Res. 2015 Sep;39(9):1632-41
pubmed: 26207424
Tumour Biol. 2016 Oct 14;:
pubmed: 27743380
Sci Rep. 2016 Mar 02;6:22519
pubmed: 26931825
Cell Death Dis. 2016 Jul 28;7(7):e2312
pubmed: 27468688
PLoS One. 2017 Jun 22;12(6):e0179510
pubmed: 28640835
Cancer Metastasis Rev. 1989 Aug;8(2):98-101
pubmed: 2673568
Cell Res. 2014 Jun;24(6):766-9
pubmed: 24710597
J Trauma Acute Care Surg. 2014 Jun;76(6):1447-55
pubmed: 24854314
J Biol Chem. 2014 Feb 14;289(7):3869-75
pubmed: 24398677
IARC Monogr Eval Carcinog Risks Hum. 2010;96:3-1383
pubmed: 21735939
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
World J Gastroenterol. 2016 Aug 7;22(29):6673-82
pubmed: 27547010
J Subst Abuse Treat. 2004 Jul;27(1):27-30
pubmed: 15223090
Alcohol. 2008 Dec;42(8):675-82
pubmed: 19038698
Dig Dis Sci. 2019 Jul;64(7):1878-1892
pubmed: 31076986
Clin Exp Metastasis. 2017 Feb;34(2):171-184
pubmed: 28168393
Nat Rev Cancer. 2018 Sep;18(9):533-548
pubmed: 30002479
World J Gastroenterol. 2014 Apr 14;20(14):3719-37
pubmed: 24744570
Oncotarget. 2016 Nov 15;7(46):76250-76260
pubmed: 27788488
Cancer Cell. 2014 Nov 10;26(5):707-21
pubmed: 25446899
Biochem Soc Trans. 2013 Feb 1;41(1):245-51
pubmed: 23356291
Mol Ther Nucleic Acids. 2012 Feb 07;1:e10
pubmed: 23344721
Eur Urol. 2017 Apr;71(4):680-687
pubmed: 27733296
Alcohol Alcohol. 2009 Mar-Apr;44(2):115-27
pubmed: 18940959
Mol Cell Proteomics. 2013 Feb;12(2):343-55
pubmed: 23161513
J Cell Biochem. 2018 May;119(5):4113-4119
pubmed: 29240249
J Hepatol. 2019 Feb;70(2):221-222
pubmed: 30658723
Cancer Res. 2013 Apr 1;73(7):2031-43
pubmed: 23536564
Oncogene. 2015 Jan 15;34(3):290-302
pubmed: 24441045
Vaccines (Basel). 2020 Dec 02;8(4):
pubmed: 33276422
Crit Care Med. 2003 Mar;31(3):869-77
pubmed: 12626999
Biochim Biophys Acta. 2014 Jan;1841(1):108-20
pubmed: 24140720
J Cancer Res Clin Oncol. 2017 Jun;143(6):991-1004
pubmed: 28285404
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
J Cancer. 2018 Aug 6;9(17):3129-3137
pubmed: 30210636
Lab Invest. 2009 Nov;89(11):1317-28
pubmed: 19786948
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
Biomed Res Int. 2014;2014:864894
pubmed: 24963487
Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L769-76
pubmed: 16006484
Curr Opin Neurobiol. 2013 Aug;23(4):513-20
pubmed: 23434064
J Immunol. 2015 Sep 15;195(6):2722-30
pubmed: 26246139
Cancer Cell. 2016 Dec 12;30(6):836-848
pubmed: 27960084
Chin J Cancer. 2016 Apr 07;35:36
pubmed: 27056366
Transl Res. 2019 Jul;209:22-38
pubmed: 30853445
Tumour Biol. 2015 Mar;36(3):1619-25
pubmed: 25528214
Dig Dis Sci. 2019 Jun;64(6):1460-1469
pubmed: 30673984
Biochim Biophys Acta. 2012 Nov-Dec;1819(11-12):1154-63
pubmed: 22982408
PLoS One. 2013;8(1):e53028
pubmed: 23326376
Eur Urol. 2015 Jan;67(1):33-41
pubmed: 25129854
Lipids Health Dis. 2017 Feb 22;16(1):44
pubmed: 28228158
Eur J Pharm Sci. 2017 Feb 15;98:70-79
pubmed: 27751843
Toxicol Lett. 2015 May 5;234(3):194-200
pubmed: 25746479
Alcohol Clin Exp Res. 2017 May;41(5):880-882
pubmed: 28295407
Alcohol Alcohol. 2017 Jul 1;52(4):403-413
pubmed: 28482009
Oncotarget. 2016 Mar 29;7(13):16923-35
pubmed: 26943577
Cancer Biomark. 2019;26(1):69-77
pubmed: 31306108
Mediators Inflamm. 2013;2013:586895
pubmed: 23606793
Blood. 2003 Dec 15;102(13):4336-44
pubmed: 12881314
Cell Rep. 2016 May 3;15(5):978-987
pubmed: 27117408
Liver Int. 2012 Mar;32(3):467-75
pubmed: 22098272
PLoS One. 2017 Aug 17;12(8):e0183337
pubmed: 28817685
EMBO J. 2011 Aug 31;30(17):3481-500
pubmed: 21878991
Hepatology. 2017 Feb;65(2):475-490
pubmed: 27639178
Nat Med. 2012 Jun;18(6):883-91
pubmed: 22635005
J Biol Chem. 2003 Feb 14;278(7):5277-84
pubmed: 12446667
Trends Biochem Sci. 2017 Jan;42(1):42-56
pubmed: 27669649
Eur J Neurosci. 2008 Oct;28(8):1641-53
pubmed: 18979677
Science. 2010 Jan 1;327(5961):46-50
pubmed: 20044567
J Clin Endocrinol Metab. 2011 May;96(5):1424-30
pubmed: 21325464
BMC Cancer. 2017 Nov 09;17(1):730
pubmed: 29121858
Cancer Res. 2006 Sep 15;66(18):9290-8
pubmed: 16982774
Elife. 2016 Feb 27;5:e10250
pubmed: 26920219
Chest. 2002 Dec;122(6 Suppl):309S-314S
pubmed: 12475807
Nat Rev Gastroenterol Hepatol. 2015 Jul;12(7):387-400
pubmed: 26055245
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):455-466
pubmed: 28634412
J Hepatol. 2019 Feb;70(2):260-272
pubmed: 30658727
Biotechnol Bioeng. 2016 Jun;113(6):1315-24
pubmed: 26574179
Life Sci. 2020 Nov 1;260:118417
pubmed: 32931801
World J Gastroenterol. 2010 Mar 21;16(11):1304-13
pubmed: 20238396
Nat Rev Dis Primers. 2018 Aug 16;4(1):16
pubmed: 30115921
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
Oncogene. 2013 May 30;32(22):2747-55
pubmed: 22797057
J Clin Invest. 2005 Jan;115(1):44-55
pubmed: 15630443
J Pharmacol Exp Ther. 2009 Jun;329(3):952-8
pubmed: 19276402
J Proteomics. 2010 Sep 10;73(10):1907-20
pubmed: 20601276
J Cell Biol. 1999 Nov 1;147(3):599-610
pubmed: 10545503
Aging (Albany NY). 2020 May 3;12(9):8352-8371
pubmed: 32364530
Gut. 2020 Jan;69(1):191-193
pubmed: 30518529
Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):664-672
pubmed: 32016967
Blood Cells Mol Dis. 2005 Nov-Dec;35(3):398-403
pubmed: 16203162
Nat Med. 2011 Jun 26;17(7):867-74
pubmed: 21706029
J Neuroimmune Pharmacol. 2020 Sep;15(3):409-421
pubmed: 30955131
Breast Cancer Res. 2016 Sep 08;18(1):90
pubmed: 27608715
Br J Cancer. 2015 Feb 3;112(3):580-93
pubmed: 25422909
Oncol Rep. 2012 Nov;28(5):1551-8
pubmed: 22895844
Oncology. 2010;79(1-2):144-9
pubmed: 21150229
Nat Commun. 2011;2:282
pubmed: 21505438
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394

Auteurs

Murali R Kuracha (MR)

Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, United States.

Peter Thomas (P)

Department of Surgery, Creighton University School of Medicine, Omaha, NE 68178, United States.

Martin Tobi (M)

Research and Development Service, Detroit VAMC, Detroit, MI 48201, United States.

Benita L McVicker (BL)

Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH